Condition
Analgesic Rebound Headache
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Propofol
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 4 (1)
Trial Status
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Propofol1
- Almotriptan1
- Topiramate1
Active Sponsors
- The New England Center for Headache, P.C.1
- University of Alberta1
- Ortho-McNeil Neurologics, Inc.1
Top Investigators
University of Alberta
The New England Center for Headache, P.C.
Related Conditions
- Headache Intractable1
- Chronic Daily Headache1
- Chronic Headache1